HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

salubrinal

prevents dephosphorylation of eIF2alpha; structure in first source
Networked: 125 relevant articles (13 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yokota, Hiroki: 10 articles (12/2020 - 09/2012)
2. Hamamura, Kazunori: 6 articles (11/2021 - 09/2012)
3. Zhang, Ping: 6 articles (12/2020 - 09/2012)
4. Anuncibay-Soto, Berta: 4 articles (12/2019 - 01/2016)
5. Fernández-López, Arsenio: 4 articles (12/2019 - 01/2016)
6. Santos-Galdiano, María: 4 articles (12/2019 - 01/2016)
7. Li, Jie: 3 articles (12/2020 - 01/2017)
8. Li, Xinle: 3 articles (12/2020 - 01/2017)
9. Liu, Daquan: 3 articles (12/2020 - 01/2017)
10. Wang, Tao: 3 articles (01/2019 - 06/2015)

Related Diseases

1. Inflammation (Inflammations)
2. Hypoxia (Hypoxemia)
3. Arthritis (Polyarthritis)
4. Neoplasms (Cancer)
5. Burns

Related Drugs and Biologics

1. Tunicamycin
2. Proteins (Proteins, Gene)
3. Caspase 3 (Caspase-3)
4. Therapeutic Uses
5. Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)
6. Eukaryotic Initiation Factor-4F (EIF4F)
7. Eukaryotic Initiation Factor-4E
8. Amylases
9. 4- ((3Z)- 3- ((5- (4- nitrophenyl)furan- 2- yl)methylidene)- 2- oxo- 5- phenylpyrrol- 1- yl)benzoic acid
10. 2- cyclohexylidenhydrazo- 4- phenyl- thiazole

Related Therapies and Procedures

1. Therapeutics
2. Intra-Articular Injections
3. Drug Therapy (Chemotherapy)
4. Oral Administration